Actinium Pharmaceuticals
ATNM
#10399
Rank
C$62.8 M
Marketcap
C$2.00
Share price
-3.38%
Change (1 day)
3.27%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): C$14.24 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are C$35.09 Million. In 2025 the company made an earning of -C$50.63 Million, an increase over its 2024 earnings that were of -C$58.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$14.24 M-128.13%
2025 -C$50.63 Million-13.95%
2024 -C$58.84 Million-18.87%
2023 -C$72.53 Million52.24%
2022 -C$47.64 Million36.61%
2021 -C$34.87 Million11.48%
2020 -C$31.28 Million1.46%
2019 -C$30.83 Million-7.37%
2018 -C$33.29 Million-11.46%
2017 -C$37.59 Million10.67%
2016 -C$33.97 Million15.7%
2015 -C$29.36 Million-14.86%
2014 -C$34.49 Million129.19%
2013 -C$15.05 Million-8.55%
2012 -C$16.46 Million
2010 C$0.01 M-152.15%
2009 -C$0.03 Million-39.8%
2008 -C$0.04 Million120.29%
2007 -C$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-C$51.95 Million-489.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$0.26 M-98.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.20 B 1,460.38%๐Ÿ‡บ๐Ÿ‡ธ USA